Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1909studies shown
Showing 469-480 of 1,909
Other study type icon
CompletedNCT00001772

Evaluation of people with Rapid Cycling Bipolarity (RCBD)

This summary needs review. Please check the official study record and contact the research team for details.

In Bethesda
Why is this study shown?

This study is directly about Bipolarity.

BipolarityObservationalA study where researchers collect information without assigning a treatment.
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Bipolarity
Drug study icon
TerminatedNCT02893371

Longitudinal Comparative Effectiveness of Bipolarity Therapies

This summary needs review. Please check the official study record and contact the research team for details.

In Albuquerque
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrug
Countries
United States
Sponsor
University of New Mexico
Condition
Bipolarity
Other study type icon
CompletedNCT00001652

The Evaluation and Follow-up of people with Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Bethesda
Why is this study shown?

This study is directly about Bipolarity.

BipolarityObservational
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Bipolarity
Drug study icon
Recruitment unclearEUCTR 2012-000778-46

Elucidation of Lithium Working Mechanism in Bipolarity by means of Multi Modal Brain Imaging (LiBiDi)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrug
Countries
Germany
Sponsor
Forschungszentrum Jülich GmbH
Condition
Bipolarity
Drug study icon
Recruitment unclearEUCTR 2008-000370-20

Evaluation of pharmacokinetic and pharmacodynamic interactions between escitalopram and drugs used for the treatment of Bipolarity.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Italy
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrug
Countries
Italy
Sponsor
AZIENDA OSPEDALIERA PISANA
Condition
Bipolarity
Device study icon
CompletedNCT01909011

A Single Blind Study of Cranial Electrical Stimulation in Bipolarity type II

This summary needs review. Please check the official study record and contact the research team for details.

In New York
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 85 Years
Countries
United States
Sponsor
Beth Israel Medical Center
Condition
Bipolarity
Other study type icon
CompletedNCT00745966

Atypical Antipsychotics in Improvement of Quality of Life in Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Kyunggi-do
Why is this study shown?

This study is directly about Bipolarity.

BipolarityObservationalFrom 18 Years to 65 Years
Countries
South Korea
Sponsor
AstraZeneca
Condition
Bipolarity
Behavioral study icon
CompletedNCT04859647

Client-led Online Therapy for People Diagnosed With Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Manchester
Why is this study shown?

This study is directly about Bipolarity.

BipolarityBehavioralOver 18 Years
Countries
United Kingdom
Sponsor
University of Manchester
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.